SANWAY, the clinical laboratory branch of SANSURE biotech have reached 99.9% accurate rate of non-invasive prenatal screening.

As the first released gene detect project, noninvasive prenatal DNA screening stand out from thousands of genetic testing projects. By examining fetal nucleic acid (genetic material) in the mother's blood, therefore to detect whether the fetus with a genetic disease, this detection can benefit the majority of pregnant women and families, especially the elderly maternal.Only 5-10 ml of peripheral venous blood is required from early pregnant women to determine the occurrence of fetal down's baby and other related risk of chromosomal diseases.

news and photos from http://www.cshtz.gov.cn/art/2016/6/14/art_36_96653.html